Cresco assisted Bedal in the structuring, negotiation and closing of its EUR 2.6 million Series A investment round.
Bedal is an award-winning start-up that develops innovative medical devices for catheter fixation.
The funding round was led by F3 Finance, an investment office for a number of Belgian families, and LRM, the Limburg Investment Company.
The company, located in the Health & Care incubator BioVille in Hasselt, will use the funds to bring its unique proprietary catheter fixation technology to the European market, and to further expand its product range with novel devices.
More information on the transaction can be found here.
For any further information or questions, please contact Yannick Verrycke.